| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 70.000 | 329.345 | 315.781 | 358.480 | 405.650 | 488.372 | 561.977 | 645.480 |
| Total Income - EUR | - | - | 70.977 | 331.526 | 316.168 | 358.487 | 405.651 | 488.373 | 561.978 | 645.545 |
| Total Expenses - EUR | - | - | 76.684 | 280.691 | 274.036 | 318.630 | 397.363 | 459.298 | 517.211 | 607.521 |
| Gross Profit/Loss - EUR | - | - | -5.707 | 50.835 | 42.132 | 39.857 | 8.288 | 29.075 | 44.767 | 38.024 |
| Net Profit/Loss - EUR | - | - | -6.417 | 47.512 | 38.970 | 35.973 | 4.173 | 24.502 | 38.143 | 31.699 |
| Employees | - | - | 3 | 6 | 6 | 7 | 8 | 8 | 7 | 8 |
Check the financial reports for the company - Farmacia Eligiafarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 57 | 56 | 20.814 | 20.052 | 10.375 | 2.078 | 429 |
| Current Assets | - | - | 65.786 | 212.721 | 282.733 | 240.445 | 239.883 | 254.694 | 230.711 | 259.597 |
| Inventories | - | - | 62.830 | 155.814 | 182.615 | 174.149 | 158.644 | 140.125 | 160.428 | 168.274 |
| Receivables | - | - | 2.172 | 40.023 | 63.907 | 51.761 | 45.929 | 60.729 | 61.056 | 76.303 |
| Cash | - | - | 784 | 16.884 | 36.211 | 14.535 | 35.310 | 53.839 | 9.227 | 15.020 |
| Shareholders Funds | - | - | -6.373 | 41.256 | 79.427 | 113.894 | 75.111 | 99.846 | 51.221 | 32.375 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 72.159 | 171.522 | 203.361 | 147.364 | 184.823 | 165.223 | 181.568 | 227.789 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -138 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Eligiafarm Srl